Expression and Significance of CDC25B, PED/PEA-15 in Esophageal Carcinoma
Cancer Biotherapy and Radiopharmaceuticals · 2015-04 · 30 (3) · 139-145
DOI: 10.1089/cbr.2014.1701 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Cancer Biotherapy and Radiopharmaceuticals, 2015-04. Verfasst von Ming Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: 1 Department of Radiation Therapy, Cangzhou Central Hospital , Cangzhou, China. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- 1 Department of Radiation Therapy, Cangzhou Central Hospital , Cangzhou, China .
Zitieren
APA
Wang, M., Zhu, X. Y., Wang, L., & Lin, Y. (2015). Expression and Significance of CDC25B, PED/PEA-15 in Esophageal Carcinoma. Cancer Biotherapy and Radiopharmaceuticals, 30(3), 139-145. https://doi.org/10.1089/cbr.2014.1701
Vancouver
Wang M, Zhu XY, Wang L, Lin Y. Expression and Significance of CDC25B, PED/PEA-15 in Esophageal Carcinoma. Cancer Biotherapy and Radiopharmaceuticals. 2015;30(3):139-145. doi:10.1089/cbr.2014.1701
BibTeX
@article{Wang2015,
author = {Wang, Ming and Zhu, Xiao-Yang and Wang, Liang and Lin, Yu},
title = {Expression and Significance of CDC25B, PED/PEA-15 in Esophageal Carcinoma},
journal = {Cancer Biotherapy and Radiopharmaceuticals},
year = {2015},
volume = {30},
number = {3},
pages = {139--145},
doi = {10.1089/cbr.2014.1701}
}
EUVIMED